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A B S T R A C T
Purpose: To retrospectively analyze the electroclinical features, etiology, treatment, and prognosis of 21
patients with encephalopathy with hemi-status epilepticus during sleep (ESES) or hemi-continuous
spikes and waves during slow sleep (CSWSS) syndrome.
Methods: Charts of 21 patients with hemi-ESES/CSWSS syndrome followed between 1997 and 2012
were analyzed. Inclusion criteria were: (1) Focal seizures or apparently generalized seizures and focal
EEG epileptiform discharges; (2) Further occurrence of atypical absences, and myoclonic, atonic, and/or
generalized seizures; (3) Cognitive impairment and/or behavioral disturbances; (4) Hemi-continuous
spike-and-wave discharges during slow sleep in more than 85% of non-REM sleep at onset and
throughout the ESES/CSWSS period.
Results: Mean follow-up from onset of hemi-ESES/CSWSS was 8 years (range, 2–15 years). Idiopathic
cases were not identiﬁed. Unilateral polymicrogyria was found in 11, shunted hydrocephalus in four, a
porencephalic cyst associated with polymicrogyria in three, and a thalamic lesion in three children. All
started with focal seizures with or without secondary generalization. During the hemi-ESES/CSWSS
period, all children developed new types of seizure, such as negative and positive myoclonus, absences,
motor deterioration, cognitive impairment, and behavioral disturbances. All AED responders returned to
baseline cognitive development. Seven patients were refractory to AEDs.
Conclusion: Our study suggests that the hemi-ESES/CSWSS syndrome has electroclinical features
compatible with an epileptic encephalopathy. The most commonly used treatments were clobazam,
ethosuximide, and sulthiame, alone or in combination. In refractory cases, high-dose corticosteroids
were administered. Although the number of patients in this study is too low to draw deﬁnite conclusions,
we consider that in children with hemi-ESES/CSWSS secondary to a unilateral lesion, surgery should be
considered.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eiz1. Introduction
Electrical status epilepticus during sleep was ﬁrst reported in
six children in 1971 by Patry et al.1 Subsequently, Tassinari and
colleagues introduced the term encephalopathy related to
electrical status epilepticus during sleep (ESES) for the phenome-
non. The term continuous spikes and waves during slow sleepAbbreviations: PMG, polymicrogyria; PC, porencephalic cyst; FMS, focal motor
seizures; CFS, complex focal seizures; SGTCS, secondarily generalized tonic-clonic
seizures; FSE, focal status epilepticus; AA, atypical absences.
* Corresponding author at: Neurology department, ‘‘Juan P Garrahan’’ Pediatric
Hospital, Combate de los Pozos 1881. Buenos Aires, CP 1245, Argentina.
Tel.: +54 11 4824 0299; fax: +54 11 4843 6116.
E-mail address: rhcaraballo@arnet.com.ar (R.H. Caraballo).
1059-1311/$ – see front matter  2013 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2013.04.006(CSWSS)was used as a synonym.2 Here we will use the term ESES/
CSWSS to describe the EEG pattern and the clinical features of the
entity.
The clinical spectrum of and guidelines for the electroencepha-
lography (EEG) of the ESES/CSWSS syndrome have recently been
published.3–5 The syndrome may be diagnosed when ESES/CSWSS
occurs in more than 85% of non-REM sleep, however, many other
authors have used different cut-off rates5–6 and the classiﬁcation of
the ILAE does not specify the cut-off value.7 Several authors have
described isolated cases with hemi-ESES/CSWSS based on the
distribution of epileptiform activity during sleep.8–14
From the clinical point of view, deterioration of one or more
cognitive functions with or without motor, behavioral, and/or
psychomotor decline has been described in children associated
with ESES/CSWSS.15,16 ESES/CSWSS may be responsible not onlyvier Ltd. All rights reserved.
Fig. 1. Axial T1-weighted brain MRI showing extensive left PMG with atrophy of the
ipsilateral hemisphere in a 10-year-old boy.
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dysfunctions, such as severe behavioral disturbances, apraxia, and
negative myoclonus.15 Idiopathic cases and patients with benign
childhood epilepsies associated with the ESES/CSWSS syndrome
have been published.17–19 The syndrome may occur in children
with organic brain lesions, such as unilateral polymicrogyria
(PMG), hydrocephalus, and thalamic lesions.13,20–25
Treatment of the ESES/CSWSS syndrome has frequently been
disappointing. Classic and new AEDs have been switched to
benzodiazepines and ethosuximide.17 An association of valproic
acid and ethosuximide is still favored by different groups.17,19,23
Sulthiame and levetiracetam have also been used.26–29 In
refractory cases, therapeutic alternatives such as corticosteroids,
gamma-globulins, the ketogenic diet, and surgery have been
tried.30,31
There have been numerous descriptions of patients with
unilateral ESES/CSWSS, as isolated in a larger series or sometimes
compared to patients with bilateral ESES/CSWSS.3,4,6,13,20,27,32–37
However, they were not included in a well-designed methodologi-
cal study analyzing only patients with unilateral ESES/CSWSS.
The aim of this study was to describe the electroclinical
features, etiology, treatment, and prognosis of 21 patients with the
hemi-ESES/CSWSS syndrome.
2. Methods
We conducted a retrospective, descriptive study of 21
consecutive patients with hemi-ESES/CSWSS syndrome followed
between 1997 and 2012. All of them met the following inclusion
criteria: (1) Onset with focal or apparently generalized seizures
and focal EEG discharges; (2) Further appearance of atypical
absences, and myoclonic, atonic (with or without epileptic falls),
and/or generalized seizures; (3) Cognitive impairment and/or
behavioral disturbances related to the hemi-ESES/CSWSS period;
(4) Hemi-ESES/CSWSS occurring in more than 85% of non-REM
sleep, at onset and during the ESES/CSWSS period.2,5 Patients who
started with diffuse ESES/CSWSS and then evolved into hemi-ESES/
CSWSS were excluded.
Patients with other epileptic encephalopathies (e.g. Landau–
Kleffner syndrome, myoclonic astatic epilepsy with cognitive
deterioration, and Lennox–Gastaut syndrome) and focal epilepsies
with secondary bilateral synchronies not fulﬁlling the criteria for
the hemi-ESES/CSWSS syndrome were also excluded.
In this study all patients underwent at least three prolonged
sleep EEGs (more than one hour), and 12 of these 21 patients
underwent all-night video-EEG in addition to the routine EEG
recordings. The spike-wave index (SWI) on the non-REM sleep EEG
during the hemi-ESES/CSWSS period was visually calculated based
on the total number of spike-waves per unit of time or based on the
information provided by the epileptologist in the clinical charts.
Nevertheless, the fact that different epileptologists may have used
different methods for calculation of the SWI based on different
reports in the literature2,5may have caused a certain heterogeneity
in the results. The term ESES/CSWSS used here includes both the
EEG pattern and the clinical features.
Brain magnetic resonance imaging (MRI) was obtained in all
patients. Prolonged sleep EEGs were repeated two or more times
per year. Data on school achievements and neuropsychological
evaluations (Terman-Merrill or WISC III or IV) were repeatedly
obtained during the follow-up of 2 to 15 years. In the absence of
formal neuropsychological tests, based on the obtained informa-
tion the degree of cognitive changes was evaluated according to
clinical judgment in seven patients.
The onset and the resolution of the hemi-ESES/CSWSS phase
were deﬁned as the time of onset of cognitive impairment and
behavioral abnormalities and the time of signiﬁcant functionalimprovement which coincided in all cases with the time of the
onset and offset of the pattern on the EEG.38,39
Biochemical controls, urine analysis, and plasma levels of
classic AEDs were studied. The AEDs before and during the hemi-
ESES/CSWSS phase were analyzed, as well as other treatment
options such as corticosteroids, gamma-globulins, the ketogenic
diet, and surgical treatments during the hemi-ESES/CSWSS period.
Determination of efﬁcacy of the AED treatment was based on
electroclinical criteria. Response of EEG abnormalities was graded
as a normal recording, a more than 75% improvement of the SWI, a
more than 50% improvement of the SWI, a more than 30%
improvement of the SWI, focalization of the continuous general-
ized paroxysms, and no response. The percentages of improvement
of SWI were related to the baseline SWI, e.g., a 50% improvement
meant a decrease from 80% to 30%. Clinical response was
considered as the decrease of cognitive and behavioral distur-
bances. The clinical response was graded as complete disappear-
ance of clinical manifestations observed during the hemi-ESES/
CSWSS phase, and clinical improvement of more than 75%, of more
than 50%, or of more than 30%. It was a rough estimation of severity
based on the clinical data (Figs. 1–3)
3. Results
3.1. General characteristics
A total of 21 children (14 boys and 7 girls) with the hemi-ESES/
CSWSS syndrome were identiﬁed between March 1997 and April
2010 at the Garrahan Hospital of Buenos Aires.
Regarding probable etiology, 11 children had PMG, and four
presented with shunted hydrocephalus, three had porencephalic
lesions associated with PMG, and three had a thalamic lesion. PMG
was localized in the frontotemporal lobes in seven patients, in the
parietooccipital lobes in two, and in the whole hemisphere in two
other patients. The brain magnetic resonance imaging showed
unilateral involvement in all cases except in three patients with
thalamic lesions and one with hydrocephalus. From a syndromic
point of view, all patients had cerebral palsy, 17 of which presented
Fig. 2. The same patient as in Fig. 1. Sleep EEG recording shows spike-and-wave discharges in the left hemisphere in more than 85% of slow sleep.
Fig. 3. The same patient as in Figs. 1 and 2. The interictal sleep EEG recording six months later after starting therapy with sulthiame shows left occipital spikes. Behavior and
cognitive performance improved signiﬁcantly. The boy has sporadic focal motor seizures.
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was mild in 10, moderate in eight, and severe in three patients; six
of these children had had behavioral disturbances before the onset
of the hemi-ESES/CSWSS.
One patient had a positive family history of epilepsy and one of
febrile seizures. Two patients had personal antecedents of febrile
seizures, two patients had antecedents of West syndrome, and two
of neonatal seizures.
3.2. Seizures and EEG ﬁndings before the onset of hemi-ESES/CSWSS
All children had experienced focal motor seizures before the
onset of hemi-ESES/CSWSS. The seizures were associated with loss
of awareness in ﬁve (24%). Three patients (14.5%) had had focal
status epilepticus, 10 (47.5%) had had focal seizures with
secondary generalization, and four (19%) had had apparently
generalized seizures. Atypical absences were found in six patients
(28.5%). Tonic seizures were not registered. Eight patients (38%)only had had seizures during the sleep, 10 (48%) only had had
seizures while awake, and ﬁve (28.5%) had had seizures during
sleep and while awake.
The current median age of the patients is 12 years. The median
age at onset of structural focal epilepsy was 2.3 years. Median time
elapsed between the ﬁrst focal seizure and the onset of the hemi-
ESES/CSWSS syndrome was 4 years.
Before hemi-ESES/CSWSS onset, the awake EEG recordings
showed focal epileptiform abnormalities in 15 patients (70.5%) that
were multifocal in nine (43%) and focal, associated with generalized
paroxysms in three patients (14.5%). In this period, the focal spikes
became more frequent on the sleep EEG recordings. Multifocal
spikes were observed in 14 patients (66.5%) during sleep.
Asymmetric baseline EEG activity was found in 15 (70.5%) cases.
In the phase immediately previous to hemi-ESES/CSWSS onset,
a considerable increase of the interictal focal abnormalities was
observed both during wakefulness and sleep predominantly in one
hemisphere and in the anterior regions.
Table 1
General features, seizures, and EEG ﬁndings before and throughout the hemi-ESES/CSWSS period according to etiology and SWI.
General characteristics and
electroclinical ﬁndings
PMG PC and PMG Hydrocephalus Thalamic lesion
Number of patients 11 3 4 3






Mental retardation Mild and moderate Moderate Moderate and severe Moderate
Type of seizure
(pre- hemi-ESES/CSWSS period)
MFS, CFS, SGTCS, FSE, AA MFS, FS, SGTCS, MFS, CFS, SGTCS, AA MFS, CFS, SGTCS, FSE























diffuse spikes or polyspikes
Focal spikes, multifocal
spikes, diffuse spikes
Focal spikes, focal slow
waves, multifocal spikes,
bilateral spikes or polyspikes






Located in right hemisphere
4 patients, left hemisphere







Located in right hemisphere
1 patient, bilateral predominantly
in left hemisphere 2 patients




Motor deterioration + + + S
Cognitive dysfunction + + + +
Motor speech impairment + + S +
Behavioral alterations + + + +
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syndrome phase
The median age at onset of the hemi-ESES/CSWSS syndrome
was 6 years. The mean duration of ESES/CSWSS was 16 months
(range, 6–36 months).
Fifteen (71.5%) of the 21 patients continued having seizures
during the hemi-ESES/CSWSS period. Thirteen (61.5%) of them had
more severe seizures. Nineteen patients (90.5%) of 21 also
presented with new types of seizure during the hemi-ESES/CSWSS
phase. These seizures were negative myoclonus in 14 patients
(73.5%), positive myoclonus in 9 (47.5%), and absences in 11 (58%).
Ten patients had motor impairment secondary to negative
myoclonus and ﬁve had motor speech impairment.
When the children deteriorated, the following cognitive
disturbances were observed: Attention deﬁcit hyperactivity
disorder in seven (33.5%), language deterioration (nonverbal
agnosia) in ﬁve patients (24%), aggressiveness in six (28.4%),
memory deﬁcit in four patients (19%), impaired temporospatial
orientation in four patients (19%), and loss of bladder control in
three patients (14.3%). Baseline cognitive status was affected in 16
patients (76.2%). The features of the new cognitive involvement
were fundamentally different from those of baseline cognitive
function before the onset of the hemi-ESES/CSWSS period.
During the hemi-ESES/CSWSS phase, the awake EEG recording
showed more frequent focal abnormalities, multifocal spikes, and
isolated bilateral spikes and waves at 2–3 Hz, predominantly in the
anterior regions. Additionally to the hemi-ESES/CSWSS, the sleep
EEG recordings showed focal epileptic activity in nine patients
(42.8%), bilateral epileptic activity in four patients (19%), and both
focal and diffuse epileptic abnormalities in ﬁve cases (24%). In
three patients (14.3%) the hemi-ESES/CSWSS recurred, twice in one
patient and three times in two.
Table 1 shows the general features, seizures, and EEG ﬁndings
before and during the hemi-ESES/CSWSS period.
3.4. Treatment
Outcome according to the clinical criteria to evaluate response
was: (a) Seizure freedom and repeated sleep EEGs showingdisappearance of the hemi-ESES/CSWSS in eight patients (38%), of
whom the syndrome was secondary to PMG in six, to hydroceph-
alus in one, to a porencephalic cyst associated with PMG in one, (b)
signiﬁcant reduction in seizure frequency (more than 75%), and
improvement of more than 75% of the SWI in three patients
(14.3%), (c) a 50–74% seizure reduction, and improvement of more
than 50% of the SWI in two patients, (d) a 30–49% seizure
reduction, and improvement of more than 30% of the SWI in one,
and (e) no response in seven patients.
During the hemi-ESES/CSWSS phase a negative response was
found to the following AEDs: Valproic acid in six patients,
oxcarbazepine in ﬁve patients, lamotrigine in four patients,
topiramate in four patients, phenobarbital in four patients,
primidone in three patients, carbamazepine in three patients,
clonazepam in one patient, levetiracetam in four patients, ethosux-
imide in two patients, and sulthiame in two other patients. Most of
these AEDs were prescribed previous to consulting our department.
All these AEDs except ethosuximide, clobazam, sulthiame, and
clonazepam, worsened the electroclinical features of the hemi-ESES/
CSWSS in the majority of patients. A switch of these AEDs to
ethosuximide, clobazam, and sulthiame, may be the ﬁrst treatment
step to signiﬁcantly improve the electroclinical pattern.
The positive response that was seen using the different AEDs
alone or in combination, and other treatment options was the
following: clobazam and ethosuximide in two patients, clobazam
and sulthiame in two patients, ethosuximide and valproic acid in
two patients, ethosuximide and sulthiame in two patients,
ethosuximide, clobazam and sulthiame in one patient, corticoste-
roids and valproic acid in two patients, corticosteroids and
sulthiame in three patients, and corticosteroids, the ketogenic
diet, clobazam and sulthiame in two patients. Successful epilepsy
surgery was performed in three patients. In these latter three
patients, based on the refractoriness of seizures after failure of
different adequate antiepileptic schemes in high doses over a
prolonged period of time added to a bad quality of life, a
presurgical evaluation was done. All seizures were shown to arise
from the affected hemisphere. Hemispherectomy was performed
in two children and partial lesionectomy in the remaining patient.
A transient response was observed in ﬁve patients with the
following AEDs: Sulthiame (one patient), valproic acid and
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patient), levetiracetam (one patient), and diazepam in combina-
tion with sulthiame (one patient).
3.5. Outcome
Average follow-up after hemi-ESES/CSWSS onset was 8 years
(range, 2–15 years). At the last control, two patients have become
seizure free and 12 have sporadic seizures. The EEG shows focal
spikes in 14, multifocal spikes in seven, and bilateral asymmetric
spikes in eight patients. Seizures are yearly in ﬁve, half-yearly in
seven, and bi-monthly or monthly in nine. Seven patients have not
responded well to treatment.
In our study the deﬁnitive control of the seizures and the
normalization of the EEG depended on the etiology of the ESES/
CSWSS syndrome. The best results were obtained in patients
with unilateral PMG in whom the course was relatively benign.
Hemi-ESES/CSWSS disappeared in most of them and they
have only sporadic seizures. In the post hemi-ESES/CSWSS
period the duration of EEG abnormalities was signiﬁcantly
longer in the patients with underlying hydrocephalus and thalamic
lesions.
In patients who became seizure free and in those who had a
seizure reduction of more than 75%, school performance and IQ
have improved signiﬁcantly and they have returned to baseline
cognitive function. However, it should be noted that in some of
these children with structural ESES/CSWSS, it is very difﬁcult to
evaluate the neuropsychological proﬁle during the active period
of the epilepsy, mainly in the ESES/CSWSS phase.
4. Discussion
Our study suggests that the hemi-ESES/CSWSS syndrome has
electroclinical features compatible with an epileptic encephalopa-
thy. Our group of patients may have similar electroclinical features
to the classic form of the ESES/CSWSS syndrome, however this
study did not yield robust data to support this hypothesis and
further research is necessary. Unilateral PMG was the most
commonly found lesion, and the second most common was
hydrocephalus. It seems that continuous activation of paroxysmal
activity during sleep in one hemisphere may cause neuropsycho-
logical dysfunction, and this ﬁnding appears to be similar to
bilateral or diffuse ESES/CSWSS in determining neurological
deterioration. Thus, the age-dependent epileptiform discharges
in a particular period of sleep per se, regardless of their unilateral
or bilateral distribution, may play a crucial role in developing
cognitive deterioration.
The results of our study and others published corroborate that
the electroclinical criteria for the ESES/CSWSS syndrome should be
revised and that hemi-ESES/CSWSS should be included in the EEG
criteria. Isolated patients with hemi-ESES/CSWSS have been
reported in the literature3,4,6,13,20,27,32–37 and there also is an
electroclinical series of patients with ESES in mainly one
hemisphere.35
The association of PMG, a porencephalic cyst, hydrocephalus, or
a thalamic lesion and ESES/CSWSS or hemi-ESES/CSWSS has been
described.20–24,40–42 Hemi-ESES/CSWSS was deﬁned as ESES/
CSWSS limited to a single hemisphere and the authors found this
phenomenon in children with idiopathic partial epilepsy in the
ESES/CSWSS period or in the remission stage.36,37 Some of these
patients may therefore be considered similar to the children in this
series.
Intellectual deterioration was found in 16 of 21 of the patients
in our series. Other cognitive alterations, such as aggressiveness,
hyperkinetic behavior, attention deﬁcit hyperactivity disorder,
expressive language disturbances, and learning difﬁculties werealso observed. Similar cognitive dysfunctions, psychotic and
autistic behavior, and behavioral disturbances have previously
been reported.43,44
Ten patients in our series had motor impairment secondary to
negative myoclonus and ﬁve had motor speech impairment. Motor
impairment, such as pseudoataxia and even loss of independent
gait, worsening of a unilateral deﬁcit, ﬁne motor clumsiness with
distorted handwriting, dyspraxia, and dystonia have been de-
scribed associated with the ESES/CSWSS syndrome.2,45
The EEG showed high-frequency oscillations that may affect
normal brain functions in children with ESES/CSWSS.46 These
ﬁndings may explain the inhibition or involvement of the non-
affected contralateral hemisphere also participating in the cogni-
tive and behavioral disturbances.
There are reports of children with structural or idiopathic focal
epilepsies in which classic antiepileptic drugs, such as carbamaz-
epine, oxcarbazepine, phenobarbital, or phenytoin, induced
electrical status epilepticus during slow sleep; these should be
avoided.17,47 Valproic acid, lamotrigine, and topiramate, have also
been reported.17 Levetiracetam has been involved in sporadic
cases,48 and the effect of levetiracetam on focal nocturnal
epileptiform activity during sleep has been described in a
placebo-controlled double-blind cross-over study.49 To our
knowledge, either in our series of patients or in other series of
patients published4,17,27,28 this phenomenon has not been
observed in patients receiving clobazam, ethosuximide, or
sulthiame. The question is if the initial use of these AEDs before
onset of unilateral or diffuse ESES may avoid the evolution into this
particular electroclinical phenomenon.
According to the pharmacological treatment described in the
management of the ESES/CSWSS syndrome, some important issues
should be taken into account. In the ﬁrst place, it is crucial to revise
the best AEDs to introduce in the pre- ESES/CSWSS phase. In
patients with unilateral PMG, which is very frequently associated
with ESES/CSWSS or hemi-ESES/CSWSS, or in patients with
hydrocephalus associated with ESES/CSWSS or hemi-ESES/CSWSS,
the choice of AEDs in the pre-ESES/CSWSS phase should be
seriously reconsidered. Second, once the ESES/CSWSS or hemi-
ESES/CSWSS period has started, the offending AEDs should be
changed to clobazam, ethosuximide, or sulthiame, alone or in
combination. The association of valproic acid and ethosuximide
may be an alternative treatment option. In children who do not
respond to AED therapy, corticosteroids should be considered
early.17,19,31 In refractory cases, the ketogenic diet and surgical
treatment should also be considered.17,30,50,51 As our study
demonstrates that patients with focal or unilateral ESES/CSWSS
syndrome frequently have a unilateral cerebral lesion, we believe
that pharmacologic treatment should be started as soon as
possible, to timely consider surgery in refractory cases after
failure of different adequate antiepileptic schemes in high doses
over a prolonged period of time and after performing a thorough
evaluation of each individual child.
5. Conclusions
Our study suggests that the hemi-ESES/CSWSS syndrome has
electroclinical features compatible with an epileptic encephalopa-
thy. It may be a variant of the ESES/CSWSS syndrome rather than a
distinctive epileptic syndrome.
Unilateral polymicrogyria was the most commonly found
lesion. The prognosis of these patients with a malformation of
cortical development is relatively benign and thus adequate
management may avoid cognitive deterioration and surgical
intervention.
Most of the patients had cognitive deterioration. Cognitive
recovery was observed in the drug responders who returned to
S. Fortini et al. / Seizure 22 (2013) 565–571570baseline cognitive development, whereas in the drug nonrespon-
ders cognition continued to deteriorate.
In this series of patients, we recommend treatment with
clobazam, ethosuximide, and sulthiame, alone or in combination.
In refractory cases, high-dose corticosteroids may be administered.
Although the number of patients in this study is too low to draw
deﬁnite conclusions, we consider that in children with hemi-ESES/
CSWSS secondary to a unilateral lesion, surgery should be
considered.
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